Stephen JuddVICE-PRESIDENT OF PRODUCT & COMMERCIAL DEVELOPMENT
Stephen joined Apellis as Vice-President of Product & Commercial Development in January, 2017. His career in pharmaceuticals began at Schering-Plough (Merck) in Belgium, and later in New Jersey, where he led global marketing for Claritin and prepared the international launch plan for Nasonex. From there, he joined Genentech in South San Francisco, where he was commercial representative and team leader on drug development teams, successfully steering four molecules from phase I through phase III clinical development; he also built and led the marketing team which launched Lucentis, a blockbuster antibody therapeutic for the treatment of age-related macular degeneration. Most recently, he was President at Cativer Bio Insights, where he provided commercial insights and launch planning for biotechnology companies developing breakthrough therapeutics in a broad range of disease states. Stephen has an MBA from IMD in Lausanne, Switzerland.